View More Recent Stories
-
Celldex (CLDX) Initiates Global Phase 3 Program for Barzolvolimab
-
Stifel Starts Celldex Therapeutics (CLDX) at Buy
-
Wolfe Research Starts Celldex Therapeutics (CLDX) at Outperform

